# Affirm Holdings, Inc.: financial statements, quarterly

AFRM · Nasdaq · CIK 1820953 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/afrm.md) · [Financials](/companies/afrm/financials.md) · [Filings](/companies/afrm/filings.md) · [Insiders](/companies/afrm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/afrm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [179](/filings/0001820953-24-000060.md) | [228](/filings/0001820953-25-000012.md) | [195](/filings/0001820953-25-000052.md) | [224 d](/filings/0001628280-26-059279.md) | [232](/filings/0001628280-25-050295.md) | [303](/filings/0001628280-26-005855.md) | [273](/filings/0001628280-26-032294.md) | [307 d](/filings/0001628280-26-059279.md) | [320](/filings/0001628280-25-050295.md) | [401](/filings/0001628280-26-005855.md) | [334](/filings/0001628280-26-032294.md) | [388 d](/filings/0001628280-26-059279.md) |
| Operating income | $m | [(209)](/filings/0001820953-24-000060.md) | [(172)](/filings/0001820953-25-000012.md) | [(161)](/filings/0001820953-25-000052.md) | [(73.5) d](/filings/0001628280-26-059279.md) | [(133)](/filings/0001628280-25-050295.md) | [(4.3)](/filings/0001628280-26-005855.md) | [(8.4)](/filings/0001628280-26-032294.md) | [58.1 d](/filings/0001628280-26-059279.md) | [63.7](/filings/0001628280-25-050295.md) | [118](/filings/0001628280-26-005855.md) | [88.4](/filings/0001628280-26-032294.md) | [147 d](/filings/0001628280-26-059279.md) |
| Income tax | $m | [1.0](/filings/0001820953-24-000060.md) | [(0.7)](/filings/0001820953-25-000012.md) | [0.9](/filings/0001820953-25-000052.md) | [1.0 d](/filings/0001628280-26-059279.md) | [1.9](/filings/0001628280-25-050295.md) | [2.5](/filings/0001628280-26-005855.md) | [2.5](/filings/0001628280-26-032294.md) | [2.3 d](/filings/0001628280-26-059279.md) | [2.3](/filings/0001628280-25-050295.md) | [3.7](/filings/0001628280-26-005855.md) | [4.5](/filings/0001628280-26-032294.md) | [(1,448) d](/filings/0001628280-26-059279.md) |
| Net income | $m | [(172)](/filings/0001820953-25-000052.md) | [(167)](/filings/0001820953-25-000052.md) | [(134)](/filings/0001820953-25-000052.md) | [(45.1) d](/filings/0001628280-26-059279.md) | [(100)](/filings/0001628280-26-032294.md) | [80.4](/filings/0001628280-26-032294.md) | [2.8](/filings/0001628280-26-032294.md) | [69.2 d](/filings/0001628280-26-059279.md) | [80.7](/filings/0001628280-26-032294.md) | [130](/filings/0001628280-26-032294.md) | [103](/filings/0001628280-26-032294.md) | [1,617 d](/filings/0001628280-26-059279.md) |
| Diluted EPS | $ per share | [(0.57)](/filings/0001820953-24-000060.md) | [(0.54)](/filings/0001820953-25-000012.md) | [(0.43)](/filings/0001820953-25-000052.md) | not reported | [(0.31)](/filings/0001628280-25-050295.md) | [0.23](/filings/0001628280-26-005855.md) | [0.01](/filings/0001628280-26-032294.md) | not reported | [0.23](/filings/0001628280-25-050295.md) | [0.37](/filings/0001628280-26-005855.md) | [0.30](/filings/0001628280-26-032294.md) | not reported |
| Basic EPS | $ per share | [(0.57)](/filings/0001820953-24-000060.md) | [(0.54)](/filings/0001820953-25-000012.md) | [(0.43)](/filings/0001820953-25-000052.md) | not reported | [(0.31)](/filings/0001628280-25-050295.md) | [0.25](/filings/0001628280-26-005855.md) | [0.01](/filings/0001628280-26-032294.md) | not reported | [0.24](/filings/0001628280-25-050295.md) | [0.39](/filings/0001628280-26-005855.md) | [0.31](/filings/0001628280-26-032294.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0001820953-24-000060.md) | [1.0](/filings/0001820953-25-000012.md) | [1.3](/filings/0001820953-25-000052.md) | [1.0](/filings/0001628280-26-059279.md) | [1.0](/filings/0001628280-25-050295.md) | [1.2](/filings/0001628280-26-005855.md) | [1.4](/filings/0001628280-26-032294.md) | [1.4](/filings/0001628280-26-059279.md) | [1.4](/filings/0001628280-25-050295.md) | [1.5](/filings/0001628280-26-005855.md) | [1.7](/filings/0001628280-26-032294.md) | [1.6](/filings/0001628280-26-059279.md) |
| Total assets | $bn | [8.4](/filings/0001820953-23-000025.md) | [9.1](/filings/0001820953-24-000006.md) | [9.2](/filings/0001820953-24-000014.md) | [9.5](/filings/0001820953-25-000080.md) | [10.1](/filings/0001820953-24-000060.md) | [10.5](/filings/0001820953-25-000012.md) | [10.4](/filings/0001820953-25-000052.md) | [11.2](/filings/0001628280-26-059279.md) | [11.5](/filings/0001628280-25-050295.md) | [13.0](/filings/0001628280-26-005855.md) | [13.1](/filings/0001628280-26-032294.md) | [15.8](/filings/0001628280-26-059279.md) |
| Total liabilities | $bn | [5.8](/filings/0001820953-23-000025.md) | [6.4](/filings/0001820953-24-000006.md) | [6.6](/filings/0001820953-24-000014.md) | [6.8](/filings/0001820953-25-000080.md) | [7.3](/filings/0001820953-24-000060.md) | [7.7](/filings/0001820953-25-000012.md) | [7.6](/filings/0001820953-25-000052.md) | [8.1](/filings/0001628280-26-059279.md) | [8.2](/filings/0001628280-25-050295.md) | [9.4](/filings/0001628280-26-005855.md) | [9.4](/filings/0001628280-26-032294.md) | [10.3](/filings/0001628280-26-059279.md) |
| Long-term debt | $bn | not reported | not reported | not reported | [1.8](/filings/0001820953-24-000035.md) | not reported | [7.3](/filings/0001820953-25-000012.md) | [7.1](/filings/0001820953-25-000052.md) | [7.6](/filings/0001820953-25-000080.md) | [7.7](/filings/0001628280-25-050295.md) | [9.0](/filings/0001628280-26-005855.md) | [8.9](/filings/0001628280-26-032294.md) | [9.8](/filings/0001628280-26-059279.md) |
| Shareholders' equity | $bn | [2.6](/filings/0001820953-25-000052.md) | [2.6](/filings/0001820953-25-000052.md) | [2.6](/filings/0001820953-25-000052.md) | [2.7](/filings/0001628280-26-059279.md) | [2.8](/filings/0001628280-26-032294.md) | [2.8](/filings/0001628280-26-032294.md) | [2.9](/filings/0001628280-26-032294.md) | [3.1](/filings/0001628280-26-059279.md) | [3.3](/filings/0001628280-26-032294.md) | [3.5](/filings/0001628280-26-032294.md) | [3.8](/filings/0001628280-26-032294.md) | [5.5](/filings/0001628280-26-059279.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [98.9](/filings/0001820953-24-000060.md) | [74.3 d](/filings/0001820953-25-000012.md) | [208 d](/filings/0001820953-25-000052.md) | [68.8 d](/filings/0001628280-26-059279.md) | [197](/filings/0001628280-25-050295.md) | [312 d](/filings/0001628280-26-005855.md) | [210 d](/filings/0001628280-26-032294.md) | [74.6 d](/filings/0001628280-26-059279.md) | [375](/filings/0001628280-25-050295.md) | [174 d](/filings/0001628280-26-005855.md) | [387 d](/filings/0001628280-26-032294.md) | [296 d](/filings/0001628280-26-059279.md) |
| Capital expenditure | $m | [35.8](/filings/0001820953-24-000060.md) | [38.7 d](/filings/0001820953-25-000012.md) | [46.5 d](/filings/0001820953-25-000052.md) | [38.3 d](/filings/0001628280-26-059279.md) | [44.2](/filings/0001628280-25-050295.md) | [43.9 d](/filings/0001628280-26-005855.md) | [53.0 d](/filings/0001628280-26-032294.md) | [51.1 d](/filings/0001628280-26-059279.md) | [54.4](/filings/0001628280-25-050295.md) | [55.7 d](/filings/0001628280-26-005855.md) | [61.4 d](/filings/0001628280-26-032294.md) | [66.9 d](/filings/0001628280-26-059279.md) |
| Share repurchases | $m | [0.0](/filings/0001820953-23-000025.md) | [0.0 d](/filings/0001820953-25-000012.md) | [0.0 d](/filings/0001820953-25-000052.md) | [0.0 d](/filings/0001628280-26-059279.md) | not reported | not reported | [0.0 d](/filings/0001628280-26-032294.md) | [0.0 d](/filings/0001628280-26-059279.md) | not reported | not reported | [0.0 d](/filings/0001628280-26-032294.md) | [0.0 d](/filings/0001628280-26-059279.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [291](/filings/0001820953-23-000025.md) | [294](/filings/0001820953-24-000006.md) | [297](/filings/0001820953-24-000014.md) | [304](/filings/0001820953-24-000060.md) | [308](/filings/0001820953-25-000012.md) | [313](/filings/0001820953-25-000052.md) | [318](/filings/0001628280-25-050295.md) | [345](/filings/0001628280-26-005855.md) | [344](/filings/0001628280-26-032294.md) | [348](/filings/0001628280-25-050295.md) | [349](/filings/0001628280-26-005855.md) | [348](/filings/0001628280-26-032294.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.